The Influence of Type 2 Diabetes Mellitus Comorbidity Factors in COVID-19 Patients on IgM and IgG Antibody Levels of SARS-Cov-2 at M. Yunus Hospital and Harapan Dan Doa Hospital Bengkulu City
- DOI
- 10.2991/978-2-38476-072-5_3How to use a DOI?
- Keywords
- COVID-19; Comorbid Factors; Type 2 Diabetes Mellitus; IgG; IgM
- Abstract
The Coronavirus Disease 2019 (COVID-19) outbreak was officially declared a global health emergency by the WHO on January 30, 2020, and poses a high risk to countries with vulnerable health levels. COVID-19 patients may also have comorbid factors for infection with COVID-19. The results of previous studies showed that the most common comorbid factors globally were hypertension (15.8%), cardiovascular and cerebrovascular conditions (11.7%), and diabetes mellitus (DM) (9.4%). These comorbid factors can increase mortality rates in patients infected with COVID-19. This study uses an observational analytical research method in the form of a retrospective study. This study analysed the effect of the comorbid factors of type 2 diabetes mellitus in COVID-19 patients on the level of IgM and IgG anti-SARS-CoV-2 antibodies. The results showed that the comorbid factors of type 2 diabetes mellitus in COVID-19 patients did not affect IgM and IgG antibody levels. Furthermore, the difference between IgM and IgG antibody levels in COVID-19 patients with comorbid type 2 DM and patients without comorbid type 2 DM is insignificant. There is no effect of comorbid type 2 diabetes mellitus in COVID-19 patients on the level of Anti-SARS-CoV-2 IgM and IgG antibodies at M. Yunus Hospital and Harapan and Doa Hospital Bengkulu City in 2020.
- Copyright
- © 2023 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Debie Rizqoh AU - Kristin Ronaniou Haloho AU - Enny Nugraheni AU - Widyawati AU - Utari Hartati AU - Riry Ambarsary PY - 2023 DA - 2023/06/21 TI - The Influence of Type 2 Diabetes Mellitus Comorbidity Factors in COVID-19 Patients on IgM and IgG Antibody Levels of SARS-Cov-2 at M. Yunus Hospital and Harapan Dan Doa Hospital Bengkulu City BT - Proceedings of the International Conference On Multidisciplinary Studies (ICOMSI 2022) PB - Atlantis Press SP - 17 EP - 24 SN - 2352-5398 UR - https://doi.org/10.2991/978-2-38476-072-5_3 DO - 10.2991/978-2-38476-072-5_3 ID - Rizqoh2023 ER -